Medroxyprogesterone Acetate 抗体
-
- 抗原 See all Medroxyprogesterone Acetate products
- Medroxyprogesterone Acetate
- 适用
- 请咨询
-
宿主
-
绵羊
-
克隆类型
- 多克隆
-
标记
- This Medroxyprogesterone Acetate antibody is un-conjugated
-
应用范围
- Enzyme Immunoassay (EIA)
- 纯化方法
- Ig Fraction
- 免疫原
- Medroxyprogesterone acetate (3)-BTG
- 亚型
- IgG
-
-
- 应用备注
-
ELISA: 0.1 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 9.70mg/mL (U.V. abs at 280nm)
- 缓冲液
- 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid repeated freezing and thawing.
- 储存条件
- -20 °C
-
- 抗原
- Medroxyprogesterone Acetate
- Abstract
- Medroxyprogesterone Acetate 产品
- 物质类
- Chemical
- 背景
- MPA (also known as depo provera) is a highly potent progestational steroid that has been used worldwide as a contraceptive. There has been a concern about the possibility of an increased risk of breast cancer associated with its use. On the other hand, MPA when employed at high doses (>0.5 - 1.0g / day i.m.) can produce objective remission with improved survival in about 30?% of postmenopausal women with advanced breast cancer resistant to cytotoxic drugs and endocrine therapies. Early results suggest that the response rate can be increased in patients with estrogen and / or progesterone positive receptors.Synonyms: MPA, Medroxy Progesterone Acetate, depo provera
-